Worth Venture Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-32,956
Closed -$167K 109
2019
Q3
$167K Sell
32,956
-105,401
-76% -$534K 0.1% 71
2019
Q2
$853K Hold
138,357
0.47% 29
2019
Q1
$641K Buy
138,357
+62,157
+82% +$288K 0.36% 34
2018
Q4
$318K Buy
76,200
+61,200
+408% +$255K 0.24% 53
2018
Q3
$94K Buy
+15,000
New +$94K 0.07% 92